Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention

References

• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005;352:1685–1695
   PubMed Web of Science ®Google Scholar
• Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006;47:7–12
   PubMed Web of Science ®Google Scholar
• Fuentes Q E, Fuentes Q F, Andrés V, Pello OM, Font de Mora J, Palomo GI. Role of platelets as mediators that link inflammation and thrombosis in atherosclerosis. Platelets 2013;24:255–262
   PubMed Web of Science ®Google Scholar
• Klovaite J, Benn M, Yazdanyar S, Nordestgaard BG. High platelet volume and increased risk of myocardial infarction: 39,531 participants from the general population. J Thromb Haemost 2011;9:49–56
   PubMed Web of Science ®Google Scholar
• Gibson CM, Kirtane AJ, Morrow DA, Palabrica TM, Murphy SA, Stone PH, Scirica BM, Jennings LK, Herrmann HC, Cohen DJ, et al; TIMI Study Group. Association of platelet counts on presentation and clinical outcomes in ST-elevation myocardial infarction (from the TIMI Trials). Am J Cardiol 2006;98:1–5
   PubMed Web of Science ®Google Scholar
• Ommen SR, Gibbons RJ, Hodge DO, Thomson SP. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. Am J Cardiol 1997;79:812–814
   PubMed Web of Science ®Google Scholar
• Bian C, Wu Y, Shi Y, Xu G, Wang J, Xiang M, Weng S, Jiang J, Ma J. Predictive value of the relative lymphocyte count in coronary heart disease. Heart Vessels 2010;25:469–473
   PubMed Web of Science ®Google Scholar
• Smith RA, Ghaneh P, Sutton R, Raraty M, Campbell F, Neoptolemos JP. Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J GastrointestSurg 2008;12:1422–1428
   PubMed Web of Science ®Google Scholar
• Wang D, Yang JX, Cao DY, Wan XR, Feng FZ, Huang HF, Shen K, Xiang Y. Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. Onco Targets Ther 2013;6:211–216
   PubMed Web of Science ®Google Scholar
• Templeton AJ, Ace O, McNamara MG, Al-Mubarak M, Vera-Badillo FE, Hermanns T, Seruga B, Ocaña A, Tannock IF, Amir E. Prognostic role of platelet to lymphocyte ratio in solid tumors: A systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2014;23:1204–1212
   PubMed Web of Science ®Google Scholar
• Krenn-Pilko S, Langsenlehner U, Thurner EM, Stojakovic T, Pichler M, Gerger A, Kapp KS, Langsenlehner T. The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer 2014;110:2524–2530
   PubMed Web of Science ®Google Scholar
• Azab B, Shah N, Akerman M, McGinn JT Jr. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis 2012;34:326–334
   PubMed Web of Science ®Google Scholar
• Yildiz A, Yuksel M, Oylumlu M, Polat N, Akyuz A, Acet H, Aydin M, Ulgen MS. The utility of the platelet–lymphocyte ratio for predicting no reflow in patients with st-segment elevation myocardial infarction. (Published online January 14, 2014)
   Google Scholar
• Temiz A, Gazi E, Güngör Ö, Barutçu A, Altun B, Bekler A, Binnetoğlu E, Şen H, Güneş F, Gazi S. Platelet/lymphocyte ratio and risk in-hospital mortality in patients with ST-elevated myocardial infarction. Med Sci Monit 2014;22:660–665
   Google Scholar
• Liu Q, Wang T, Chen R, Liu C, Yue W, Hong J, Jia R. Mean platelet volume predicts left descending artery occlusion in patients with non-ST-elevation myocardial infarction. Platelets 2014;25:246–251
   PubMed Web of Science ®Google Scholar
• Koseoglu HI, Altunkas F, Kanbay A, Doruk S, Etikan I, Demir O. Platelet-lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome (Published online July 8, 2014). J Thromb Thrombolysis. 2014; in press
   Google Scholar
• Choi SW, Choi DH, Kim HW, Ku YH, Ha SI, Park G. Clinical outcome prediction from mean platelet volume in patients undergoing percutaneous coronary intervention in Korean cohort: Implications of more simple and useful test than platelet function testing. Platelets 2014;25:322–327
   PubMed Web of Science ®Google Scholar
• Kurtul A, Murat SN, Yarlioglues M, Duran M, Karadeniz M, Ergun G, Akyel A, Mendi MA, Oksuz F. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease (Published online, May 4, 2014). Platelets: 1–5; in press
   Google Scholar
• Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, Meghani M, Akhtar M, Costantino T. Neutrophil to lymphocyte ratio and cardiovascular diseases: A review. Expert Rev Cardiovasc Ther 2013;11:55–59
   PubMedGoogle Scholar
• Murat SN, Duran M, Kalay N, Gunebakmaz O, Akpek M, Doger C, Elcik D, Ocak A, Vatankulu MA, Turfan M, et al. Relation between mean platelet volume and severity of atherosclerosis in patients with acute coronary syndromes. Angiology 2013;64:131–136
   PubMed Web of Science ®Google Scholar
• Akin F, Köse N, Ayça B, Katkat F, Duran M, Uysal OK, Arinc H. relation between red cell distribution width and severity of coronary artery disease in patients with acute myocardial infarction. Angiology 2013;64:592–596
   PubMed Web of Science ®Google Scholar
• Azab B, Torbey E, Singh J, Akerman M, Khoueiry G, McGinn JT, Widmann WD, Lafferty J. Mean platelet volume/platelet count ratio as a predictor of long-term mortality after non-ST-elevation myocardial infarction. Platelets 2011;22:557–566
   PubMed Web of Science ®Google Scholar
• Akin F, Ayça B, Köse N, Sahin I, Akin MN, Canbek TD, Güngör O. Effect of atorvastatin on hematologic parameters in patients with hypercholesterolemia. Angiology 2013;64:621–625
   PubMed Web of Science ®Google Scholar
• Lindemann S, Krämer B, Seizer P, Gawaz M. Platelets, inflammation and atherosclerosis. J Thromb Haemost 2007;5:203–211
   PubMed Web of Science ®Google Scholar
• Tantry US, Bliden KP, Suarez TA, Kreutz RP, Dichiara J, Gurbel PA. Hypercoagulability, platelet function, inflammation and coronary artery disease acuity: Results of the Thrombotic RIsk Progression (TRIP) Study. Platelets 2010;21:360–367
   PubMed Web of Science ®Google Scholar
• Gurbel PA, Bliden KP, Kreutz RP, Dichiara J, Antonino MJ, Tantry US. The link between heightened thrombogenicity and inflammation: Pre-procedure characterization of the patient at high risk for recurrent events after stenting. Platelets 2009;20:97–104
   PubMed Web of Science ®Google Scholar
• Iyú D, Glenn JR, White AE, Johnson AJ, Fox SC, Heptinstall S. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function. Platelets 2010;21:329–342
   PubMed Web of Science ®Google Scholar
• Verdoia M, Secco GG, Barbieri L, Cassetti E, Schaffer A, Sinigaglia F, Marino P, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS). Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. Platelets 2014;25:367–372
   PubMed Web of Science ®Google Scholar
• Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31–47
   PubMed Web of Science ®Google Scholar
• Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002;105:656–662
   PubMed Web of Science ®Google Scholar
• Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA, Pache J, Alger P, Mehilli J, Schömig A, Kastrati A. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am CollCardiol 2010;55:2383–2389
   Web of Science ®Google Scholar
• Kurtul A, Yarlioglues M, Murat SN, Ergun G, Duran M, Kasapkara HA, Demircelik MB, Cetin M, Ocek AH. Usefulness of the platelet-to-lymphocyte ratio in predicting angiographic reflow after primary percutaneous coronary intervention in patients with acute st-segment elevation myocardial infarction. Am J Cardiol 2014;114:342–347
   PubMed Web of Science ®Google Scholar
• Tanındı A, Erkan AF, Ekici B, Alhan A, Töre HF. Neutrophil to lymphocyte ratio is associated with more extensive, severe and complex coronary artery disease and impaired myocardial perfusion. Turk Kardiyol Dern Ars 2014;42:125–130
   PubMedGoogle Scholar
• Sönmez O, Ertaş G, Bacaksız A, Tasal A, Erdoğan E, Asoğlu E, Uyarel H, Göktekin O. Relation of neutrophil-to-lymphocyte ratio with the presence and complexity of coronary artery disease: An observational study. Anadolu Kardiyol Derg 2013;13:662–667
   PubMed Web of Science ®Google Scholar
• Head SJ, Davierwala PM, Serruys PW, Redwood SR, Colombo A, Mack MJ, Morice MC, Holmes DR Jr, Feldman TE, Ståhle E, et al. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: Final five-year follow-up of the SYNTAX trial (Published online May 21, 2014). Eur Heart J. 2014; in press
   Google Scholar
• Ayça B, Akın F, Celik O, Cetin S, Sahin I, Gülşen K, Kalyoncuoğlu M, Katkat F, Okuyan E, Dinçkal MH. Whether Syntax Score predicts in hospital outcomes in patients with ST elevation myocardial ınfarction undergoing primary percutaneous coronary ıntervention (Published online March 27, 2014). Kardiol Pol. 2014; in press
   Google Scholar
• Akgun T, Oduncu V, Bitigen A, Karabay CY, Erkol A, Kocabay G, Ozveren O, Yildiz A, Cimen AO, Kirma C. Baseline SYNTAX score and long-term outcome in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (Published online February 4, 2014). Clin Appl Thromb Hemost. 2014; in press
   Google Scholar
• Ugur M, Gul M, Bozbay M, Cicek G, Uyarel H, Koroglu B, Uluganyan M, Aslan S, Tusun E, Surgit O, et al. The relationship between platelet to lymphocyte ratio and the clinical outcomes in ST elevation myocardial infarction underwent primary coronary intervention (Published online January 6, 2014). Blood Coagul Fibrinolysis. 2014; in press
   Google Scholar
• Ciçek G, Açıkgoz SK, Bozbay M, Altay S, Uğur M, Uluganyan M, Uyarel H. Neutrophil-Lymphocyte ratio and platelet-lymphocyte ratio combination can predict prognosis in patients with st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. (Published online May 16, 2014). Angiology. 2014; in press
   Google Scholar